Mesa Laboratories Inc (MLAB)

Debt-to-equity ratio

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	—	155,214	161,451	150,727	145,393	402,961	387,759	387,719	393,480	387,205	374,236	380,431	393,801	396,329	399,417	399,003	406,227	412,795	392,412	382,234
Debt-to-equity ratio		—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

March 31, 2025 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $—K
= —

The debt-to-equity ratio of Mesa Laboratories Inc has remained consistently at 0.00 for the past several reporting periods, including June 30, 2020 to December 31, 2024. This indicates that the company has not utilized any debt to finance its operations or investments during this period, relying entirely on equity for its capital structure. A debt-to-equity ratio of 0.00 signifies a strong financial position with no debt obligations, which could imply lower financial risk and greater financial stability for the company. Additionally, a zero debt-to-equity ratio may indicate that Mesa Laboratories Inc has been able to fund its growth and operations internally or through equity financing, demonstrating prudent financial management. However, the absence of debt in the capital structure may also limit the company's ability to benefit from tax advantages associated with debt financing. It is important for investors and stakeholders to consider the reasons behind the lack of debt and assess the overall risk profile of the company when evaluating its financial health and performance.